Exact Sciences Corp logo

Exact Sciences Corp (EXAS)

Market Closed
24 Feb, 20:00
NASDAQ (CM) NASDAQ (CM)
$
103. 45
+0.06
+0.06%
Pre Market
$
103. 45
0 0%
19.74B Market Cap
- P/E Ratio
- Div Yield
2,072,097 Volume
-0.85 Eps
$ 103.39
Previous Close
Day Range
103.38 103.67
Year Range
38.81 103.67
Want to track EXAS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
EXAS earnings report is expected in 63 days (29 Apr 2026)
3 Biotech Stocks You Should Know About

3 Biotech Stocks You Should Know About

In June, we profiled biotech exchange-traded fund (ETF) SPDR S&P Biotech ETF (XBI) amid a historically bullish month.

Schaeffersresearch | 1 year ago
This Cathie Wood Growth Stock Could Soar by 93%, According to Wall Street

This Cathie Wood Growth Stock Could Soar by 93%, According to Wall Street

Exact Sciences is facing a barrage of headwinds. The company's financial results haven't been good of late.

Fool | 1 year ago
The 3 Best Personalized Medicine Stocks to Buy in July 2024

The 3 Best Personalized Medicine Stocks to Buy in July 2024

The personalized medicine market is experiencing significant growth, driven by advancements in genomic technologies and a shift towards more individualized healthcare. In 2024, the market is expected to continue expanding, with projections indicating it could reach approximately $390.65 billion, growing at a compound annual growth rate (CAGR) of around 8.20% from 2024 to 2030.

Investorplace | 1 year ago
Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns

Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns

We are almost halfway through 2024, and the stock market is putting on a masterclass performance. The S&P 500 is up 12% year-to-date after rising 23% last year.

Investorplace | 1 year ago
Why Is Exact Sciences (EXAS) Down 17.5% Since Last Earnings Report?

Why Is Exact Sciences (EXAS) Down 17.5% Since Last Earnings Report?

Exact Sciences (EXAS) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 year ago
Exact Sciences (EXAS) Witnesses Rising Expenses, Competition

Exact Sciences (EXAS) Witnesses Rising Expenses, Competition

Exact Sciences (EXAS) has numerous competitors, given the large market for colorectal cancer screening.

Zacks | 1 year ago
Exact Sciences (EXAS) to Showcase Favorable Research Outcome

Exact Sciences (EXAS) to Showcase Favorable Research Outcome

Exact Sciences' (EXAS) latest study research result shows commitment to innovation and strategies that expand access to effective cancer screening and diagnostic tools for patients.

Zacks | 1 year ago
Bull Market Blastoff: 3 Stocks Targeting 56% to 91% Returns

Bull Market Blastoff: 3 Stocks Targeting 56% to 91% Returns

With the S&P 500 sitting just a few points below setting a new all-time high, the bull market that began in 2022 is still snorting. Although a correction or even a bear market will eventually happen, the market is content to run higher.

Investorplace | 1 year ago
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024

Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024

The ARK Innovation ETF (NYSEARCA: ARKK ) has come under the spotlight recently, and there are three Cathie Wood stocks to buy with strong buy ratings for investors to consider in May this year. One of the key characteristics of the ARK Innovation ETF is its concentrated portfolio, typically holding between 35 to 55 stocks.

Investorplace | 1 year ago